Asia Pacific Oncology Consortium

Asia Pacific Oncology Consortium
Name	Asia Pacific Oncology Consortium
Formation	2005
Type	Non-profit organization
Headquarters	Honolulu, Hawaii
Region served	Asia-Pacific
Leader title	Chair
Leader name	Joseph S. Cheng

Asia Pacific Oncology Consortium is a regional non-profit network focused on improving cancer care across the Asia-Pacific region through capacity building, guideline dissemination, and multicenter education. The consortium brings together clinicians, academic centers, professional societies, and ministries of health to address disparities in oncology services across countries such as Japan, China, India, Australia, New Zealand, Singapore, Thailand, Philippines, and Vietnam. Its activities intersect with global oncology initiatives led by groups like the World Health Organization, the Union for International Cancer Control, and the American Society of Clinical Oncology.

History

The consortium was founded in 2005 following multisite discussions convened by stakeholders from University of Hawaii at Manoa, MD Anderson Cancer Center, and representatives of national oncology societies including the Japanese Cancer Association, Cancer Institute (WIA), and the Indian Council of Medical Research. Early milestones included multicountry workshops modeled after programs at Dana-Farber Cancer Institute and curricula influenced by the European Society for Medical Oncology Fellowship framework. During its first decade, the consortium expanded events to partner institutions such as Prince of Wales Hospital (Hong Kong), National Cancer Center Hospital (Tokyo), and the National Cancer Centre Singapore, while aligning with regional public health efforts led by the Asia Pacific Academic Consortium for Public Health and the Asia-Pacific Economic Cooperation health working groups.

Mission and Objectives

The consortium’s mission emphasizes workforce development, guideline adaptation, and equitable access to evidence-based oncology practices across metropolitan hubs and rural provinces in countries like Indonesia, Malaysia, Sri Lanka, and Pakistan. Core objectives include: strengthening clinical oncology training in collaboration with institutions such as Monash University, promoting multidisciplinary tumor board models practiced at Seoul National University Hospital, and facilitating translational research partnerships with centers including the Peter MacCallum Cancer Centre. The consortium articulates measurable targets that echo commitments made at forums like the World Health Assembly and regional declarations involving the Association of Southeast Asian Nations health ministers.

Governance and Organizational Structure

Governance is overseen by a board comprising academic directors from member institutions such as University of Sydney, Peking University Cancer Hospital, and representatives of national societies including the Korean Cancer Association and the Malaysian Oncological Society. Committees mirror structures found in entities like the International Agency for Research on Cancer and include an Education Committee, Research Committee, and Policy Liaison Group. Operational coordination occurs via secretariats hosted alternately by partner centers—past hosts include University of Hong Kong and Aga Khan University. Funding streams historically derive from philanthropic foundations such as the Bill & Melinda Gates Foundation, government grants from agencies like the Japan International Cooperation Agency, and industry partners including multinational pharmaceutical companies headquartered in Switzerland and United States.

Programs and Initiatives

Signature programs include regional training workshops modeled on curricula from Royal College of Physicians and hands-on fellowships at hospitals like St. Vincent’s Hospital (Australia). The consortium runs a Tumor Board Telemedicine Initiative connecting centers in Fiji and Papua New Guinea with specialists from M.D. Anderson Cancer Center, and a Palliative Care Outreach program aligned with best practices championed by the European Association for Palliative Care. Other initiatives involve guideline adaptation projects referencing standards from the National Comprehensive Cancer Network, capacity assessments using tools similar to those developed by the Global Health Workforce Alliance, and advocacy campaigns coordinated with the Union for International Cancer Control.

Research and Education

Research priorities emphasize implementation science, clinical trial networks, and registry development in partnership with registries like the Thai National Cancer Institute database and the Australian Cancer Database. Educational offerings include short courses on chemotherapy safety inspired by protocols from the Institute of Cancer Research (UK), online modules leveraging platforms used by Coursera collaborators, and mentorship programs pairing early-career oncologists with senior faculty from institutions such as Johns Hopkins University and Harvard Medical School. Multicenter observational studies have been conducted with contributions from Osaka University, University of Malaya, and National Taiwan University Hospital to assess treatment outcomes and resource-appropriate protocols.

Partnerships and Collaborations

The consortium maintains partnerships with international bodies including the World Health Organization, the Union for International Cancer Control, and regional agencies like the Asia-Pacific Observatory on Health Systems and Policies. Academic collaborations extend to centers such as Yale School of Medicine, UCLA, and Karolinska Institutet. It coordinates policy dialogues with ministries of health across the Pacific Islands Forum membership and works with nongovernmental organizations such as Helen Keller International for cancer prevention and screening campaigns. Industry engagement has included cooperative agreements with diagnostic companies and pharmaceutical sponsors to support training and infrastructure.

Impact and Outcomes

Measured outcomes include enhanced oncology fellowship placements at partner hospitals, increased adoption of adapted clinical pathways in tertiary centers across Bangladesh and Nepal, and implementation of teleconsultation services in remote provinces of Philippines and Indonesia. Publications arising from consortium-supported studies have appeared in journals affiliated with societies like the American Association for Cancer Research and the Journal of Clinical Oncology-adjacent literature. Program evaluations report improvements in chemotherapy safety practices, stronger tumor registry completeness modeled after Surveillance, Epidemiology, and End Results Program, and sustained networks that continue to influence cancer policy discussions at regional summits such as those organized by the Asia-Pacific Economic Cooperation health track.

Category:International medical and health organizations Category:Cancer organizations